CHRISTINE RUE: Open Payments
NPI 1821339862 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 22 payments from 7 companies in 2025. Trend: 2023 $320 · 2024 $217 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $185 |
| Amgen Inc. | 6 | $130 |
| Novo Nordisk Inc | 2 | $47 |
| Corcept Therapeutics | 2 | $38 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: EVENITY, QULIPTA, Korlym, VRAYLAR, TZIELD, LEQVIO, BEXSERO, UBRELVY.
Industry payments across OR — which companies pay providers there.
